What is Protera?
Protera is at the forefront of innovation in the food industry, specializing in the development of next-generation functional ingredients. Leveraging advanced protein engineering and artificial intelligence, the company's madi platform is designed to tackle complex protein development challenges. This includes identifying unique protein functions and optimizing protein performance. Protera employs generative AI and computational biology to drive protein creation through precision fermentation at an industrial scale, aiming to revolutionize food products and materials.
How much funding has Protera raised?
Protera has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2021): $10M with participation from ICL Planet, Sofinnova Partners, Bimbo Group, and SOSV LLC
Key Investors in Protera
ICL Planet
ICL Planet is an investor participating in this funding round. Further details on their specific investment focus are not publicly available.
Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact the company's collective future.
Bimbo Group
Bimbo Group is an investor participating in this funding round. Further details on their specific investment focus are not publicly available.
What's next for Protera?
The recent major strategic investment signals a pivotal growth phase for Protera, likely enabling the company to scale its operations, expand its research and development capabilities, and further commercialize its protein engineering and AI-driven solutions. This capital infusion is expected to accelerate the company's mission to innovate protein creation for diverse applications within the food industry and beyond.
See full Protera company page
